Condition (MeSH)
Pancreatic Pseudocyst
ClinicalTrials.gov lists 31 trials for Pancreatic Pseudocyst or a narrower condition beneath it. Xlumena, Inc. has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
31 of the 31 trials are tagged with Pancreatic Pseudocyst itself; the rest are tagged with a narrower condition beneath it.
When did Pancreatic Pseudocyst trials start? (18)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 2 |
| 2024 | 2 |
| 2023 | 3 |
| 2022 | 1 |
| 2021 | 1 |
| 2019 | 2 |
| 2018 | 2 |
| 2017 | 2 |
| 2016 | 2 |
| 2015 | 1 |
Showing 10 of 18 earlier years.
No forecast is made for this condition: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Pancreatic Pseudocyst trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 4 | 1 |
| Not applicable | 19 |
| Observational | 9 |
How many Pancreatic Pseudocyst trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 5 |
| Completed | 14 |
| Terminated | 2 |
| Withdrawn | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Pancreatic Pseudocyst trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Xlumena, Inc. | 2 |
| Boston Scientific Corporation | 1 |
| Boston Scientific Japan K.K. | 1 |
| Laser Tissue Welding, Inc. | 1 |
Which serious adverse events do Pancreatic Pseudocyst trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Pancreatitis | 11 | 2 |
| Abdominal Pain | 6 | 1 |
| Infected pseudocyst | 3 | 1 |
| Infection | 3 | 1 |
| Abdominal pain | 2 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Pancreatic Pseudocyst? (55)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
Showing 5 of 55 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: drugs tested, prevalence, rare-disease identity, and sub-conditions in mesh.